Each<unk>  binds only one specific antigen.<unk>  is a form of immunotherapy that uses<unk> <unk> es (mAbs) to bind monospecifically to certain cells or proteins. The objective is that this treatment will stimulate the patient's immune system to attack those cells. Alternatively, in radioimmunotherapy a radioactive dose localizes a target cell line, delivering lethal chemical doses.<unk> es have been used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses. This is known as immune checkpoint therapy. It is possible to create a mAb that is specific to almost any extracellular/cell surface target. Research and development is underway to create<unk> es for diseases (such as rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Ebola and different types of cancers).
Monoclonal antibody therapy
Anti–vascular endothelial growth factor therapy
Targeted therapy
Collagen induction therapy
Radionuclide therapy
Stem-cell therapy
Chemoimmunotherapy
Peptide receptor radionuclide therapy